Shouyao Holdings (Beijing) Co., LTD.

688197

CNE1000062V6

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. Other stock markets 16/06/2026			5-day change	1st Jan Change
31.13 ^CNY	-1.17%		+2.10%	-10.39%

04-17	Shouyao Holdings Co., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-15	Shouyao Holdings Co., LTD. announced that it expects to receive CNY 300 million in funding	CI

Shouyao Holdings Gets Ethical Approval for Tumor Clinical Trials

Published on 04/28/2025 at 10:10 am BST - Modified on 04/28/2025 at 10:13 am BST

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Shouyao Holdings (Beijing) Co., LTD.

04-17	Shouyao Holdings Co., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-15	Shouyao Holdings Co., LTD. announced that it expects to receive CNY 300 million in funding	CI
02-05	Shouyao Holdings Obtains Approval for Cancer Drug Trial	MT
01-30	Shouyao Holdings Co., LTD. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12-12	Shouyao Holdings plans to seek Hong Kong listing	RE
30/10/25	Shouyao Holdings Co., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
27/08/25	Shouyao Holdings Co., LTD. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
28/04/25	Shouyao Holdings Gets Ethical Approval for Tumor Clinical Trials	MT
27/04/25	Shouyao Holdings Co., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
17/01/25	Shouyao Holdings Co., LTD. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
27/10/24	Shouyao Holdings Co., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
25/08/24	Shouyao Holdings Co., LTD. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
28/04/24	Shouyao Holdings Co., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
22/03/24	1,859,000 A Shares of Shouyao Holdings Co., LTD. are subject to a Lock-Up Agreement Ending on 23-MAR-2024.	CI
14/03/24	China Healthcare Stocks Rally on Hopes for Government Support	DJ

Chart Shouyao Holdings (Beijing) Co., LTD.

Duration

Period

Chart Shouyao Holdings (Beijing) Co., LTD.

688197: Dynamic Chart

Shouyao Holdings Co Ltd is a China-based company mainly engaged in the discovery and development of innovative small molecule therapies in the field of cancer. The Company's independently developed product pipeline mainly includes SY-707, SY-3505, SY-5007, SY-5933, SY-4798, SY-4835, SY-9453, SY-7166, SY-12321, and SY-14556. The company's collaborative developed product pipeline mainly includes CT-1139/TQ-B3139, CT-1995/TQ05105, CT-2755/TQ-B3454, CT-034/TQ-B3234, CT-2426/TQ-B3455, CT-133/CSPCHA115, CT-1495/TQ-B3395, CT-1803/TQ-B3303, CT-3417/TQ-B3558, CT-3872/TQ-B3811 and CT-4460/TQ-B3617. The Company operates its businesses in the domestic market.

Employees

172

Sector

Biotechnology & Medical Research

More about the company